Armstrong, Amy E.
Belzberg, Allan J.
Crawford, John R.
Hirbe, Angela C.
Wang, Zhihong J.
Funding for this research was provided by:
AstraZeneca and Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Article History
Received: 7 February 2023
Accepted: 22 May 2023
First Online: 16 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: AA received consultancy fees from Springworks Therapeutics; payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from Alexion, Prime Pharmaceuticals, and EM Partners; and has participated on a Data Safety Monitoring or Advisory Board for Alexion. AB received grants or contracts from the Neurosurgery Pain Research Institute, John Hopkins School of Medicine. JC reports no conflicts of interest. AH received royalties or licenses from Boehringer Ingelheim and Deutsches Krebsforschungszentrum; consultancy fees from Intellisphere LLC and Springworks Therapeutics; payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from EM Partners; has participated on a Data Safety Monitoring or Advisory Board for Alexion and AstraZeneca Pharmaceuticals; and has received equipment, materials, drugs, medical writing support, gifts, or other services from Alexion, AstraZeneca Rare Diseases. ZW received consultancy fees, payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events, and participated on a Data Safety Monitoring or Advisory Board for AstraZeneca. ZW also acts as an honorary chair for a local NF group.